作者
Andrea Jegerlehner, Alain Tissot, Franziska Lechner, Peter Sebbel, Iris Erdmann, Thomas Kündig, Thomas Bächi, Tazio Storni, Gary Jennings, Paul Pumpens, Wolfgang A Renner, Martin F Bachmann
发表日期
2002/8/19
期刊
Vaccine
卷号
20
期号
25-26
页码范围
3104-3112
出版商
Elsevier
简介
Virus like particles (VLPs) are known to induce potent B cell responses in the absence of adjuvants. Moreover, epitope-specific antibody responses may be induced by VLPs that contain peptides inserted in their immunodominant regions. However, due to steric problems, the size of the peptides capable of being incorporated into VLPs while still permitting capsid assembly, is rather limited. While peptides genetically fused to either the N- or C-terminus of VLPs present fewer assembly problems, the immune responses obtained against such epitopes are often limited, most likely because the epitopes are not optimally exposed. In addition, such particles may be less stable in vivo. Here, we show that peptides and proteins engineered to contain a free cys can be chemically coupled to VLPs formed from the hepatitis B core antigen (HBcAg) containing a lys in the immuno-dominant region. By using this approach steric …
引用总数
20022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024141118211724172311251822212313810128993